VLCAD deficiency

Explore clinical trials studying VLCAD deficiency. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

VLCAD deficiency trial results

Completed

Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

NCT01379625

Conditions: Carnitine Palmitoyltransferase 2 (CPT2) Deficiency, Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency, Mitochondrial Trifunctional Protein (TFP) Deficiency, +2 more
Locations: Oregon Health & Science University Portland, Oregon, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment

NCT00499070

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +28 more
Locations: St. Anna Children's Hospital Vienna, Austria

Ghent University Ghent, Belgium

University Hospital Motol Prague, Czechia

Arhus Universitetshospital - Skejby Aarhus, Denmark

View Trial Details

Completed

Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects

NCT00983788

Conditions: Carnitine Palmitoyltransferase II Deficiency, Carnitine palmitoyl transferase 2 deficiency, VLCAD deficiency, +1 more
Locations: Neuromusculare Research Unit, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids

NCT00328159

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Inborn Errors of Metabolism, +4 more
Locations: Necker University Hospital - Metabolism Unit Paris, France

View Trial Details

Active, Not Recruiting

A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

NCT05933200

Conditions: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), VLCAD deficiency
Locations: General University Hospital in Prague-GUH (Všeobecná fakultní nemocnice v Praze- VFN) Prague, Czechia

Universitätsklinikum Freiburg Freiburg im Breisgau, Germany

Juntendo University Hospital Bunkyo City, Tokyo, Japan

The Jikei University Hospital Minato, Tokyo, Japan

View all 15 locations

View Trial Details

Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States

View Trial Details

Active, Not Recruiting

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

NCT04632953

Conditions: Carnitine-Acylcarnitine Translocase Deficiency, Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Trifunctional Protein Deficiency With Myopathy And Neuropathy, +1 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

University of California San Francisco San Francisco, California, United States

Children's Hospital of Colorado Aurora, Colorado, United States

University of South Florida Tampa, Florida, United States

View all 16 locations

View Trial Details

VLCAD deficiency

VLCAD deficiency trial results

Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment

Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects

Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids

A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

Early Check: Expanded Screening in Newborns

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

Related conditions